Nucleati

Physicians rely on the latest, high-quality evidence to tailor patient care. However, as necessary as it is, high-quality, reliable, transparent, unbiased, and updated data that help to practice “precision medicine” or “evidence-based medicine” is not readily available. Nucleati uses cutting-edge technologies to help collect, curate, store, and distribute high-quality medical evidence.

We offer services for:
1. Development of entire informatics infrastructure to support high-quality, medical grade, structured evidence generation.
2. Development of web-enabled applications to apply guideline-based inferencing and assertion generation
3. Use of artificial intelligence to fully automate the collection, curation, and normalization of relevant evidence

Some of the products developed in these regards include:
1. Nucleati Abstracts: A low latency REST-APIs to access more than 30 million abstracts of published articles for language processing tasks.
2. Germline Cancer Evidence Base: First of its kind AI curated “evidence base” that delivers >30,000 pieces of evidence as easily browsable case reports, series, and GWAS studies of hereditary cancers and germline mutations.
3. Adverse drug reactions Evidence Base: Delivers >35000 pieces of evidence of adverse effects induced by drugs, drug-drug interactions, and individual genotypes.